Keys to preventing cancer: Unlocking barriers to HPV vaccinations in low-income countries

Vaccinating against Human Papillomavirus (HPV) is an effective method for preventing infections that can lead to cervical and other HPV-associated cancer. In many resource-limited settings where access to cancer screening and treatment is limited and cancer incidence and mortality are high, preventing HPV infection is a critical step towards reducing suffering. We aim to identify and minimize barriers that prevent adolescents from receiving HPV vaccine in low-income, high-burden settings. Uganda introduced a national HPV vaccination program in 2015. Our research will evaluate the program’s HPV vaccine uptake, identify those at greatest risk of missing vaccinations, and assess the feasibility of implementing novel interventions to increase vaccination. We will contribute to the globalization of the undergraduate curriculum by developing research ethics case studies and datasets to enhance understanding of diverse global perspectives and challenges involving population health and ethics. Ultimately, the goal is to develop tailored solutions to ensure that HPV vaccination reaches those in greatest need.